Search

everythinglearnresearchcommunity

for

Search:↓

New treatments for alopecia areata may target specific immune cells and pathways involved in hair loss.

Natural killer cells play a key role in autoimmune skin diseases like pemphigus vulgaris.

Understanding the immune-related causes of Alopecia Areata has led to potential treatments like JAK inhibitors.

Removing certain immune cells in mice causes their hair to enter the growth phase earlier than usual.

Mushroom beta-glucans from Ganoderma lucidum can reduce tumor size and metastasis in cancer.

Kang-ai injection with platinum-based chemotherapy improves tumor response and immune function while reducing side effects in advanced lung cancer.

Nk-EE may help treat hair loss by promoting hair growth and preventing hair follicle damage.

Nepenthes kampotiana extract can potentially prevent hair loss and could be an effective treatment for common baldness.

Significant progress and collaborations in stem cell research and regenerative medicine were made, including advancements in hair growth, cancer therapies, and treatments for neurological disorders.

The growth of the Epstein-Barr virus in the patient's cells was linked to the worsening of her lymphoma.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

Canine pemphigus foliaceus involves significant immune activity and shares similarities with human pemphigus.

Early intervention and patient education are crucial for managing alopecia areata.

Gefitinib and Sasam-Kyeongokgo together significantly reduce cancer growth and improve immune response in mice.

Pantethine may boost the immune system's ability to fight sarcoma.

Androgenetic alopecia involves immune cell disruptions, especially increased CD4+ T cells around hair follicles.

The study suggests that a specific type of immune cell, memory-like NK cells, may increase during active hair loss in Alopecia areata.

The study concluded that immune cells attacking hair follicles cause hair loss in alopecia, with genetics and environment also playing a role, and highlighted the potential of certain treatments.

New treatments for the autoimmune hair loss condition alopecia areata may include JAK inhibitors and other immunomodulators.

Different immune responses cause hair loss in scalp diseases, with unique patterns in scalp psoriasis possibly protecting against hair loss.

A new TP63 mutation was found in a baby with EEC syndrome, showing the need for TREC testing to check for immune issues.

Certain KIR genes in Indian SLE patients are linked to disease severity and could be biomarkers.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Low androgen levels can still cause female pattern hair loss.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

SCF and ET-1 together significantly increase skin pigmentation and melanin production.

Researchers created a mouse model of a type of rickets that does not cause hair loss.

The Arabic Skindex-16 is a reliable and valid way to measure the impact of skin conditions on quality of life in Saudi patients.